Euroapi S.A.
Euroapi S.A. (EAPIF) Financial Performance & Income Statement Overview
Analyze Euroapi S.A. (EAPIF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Euroapi S.A. (EAPIF) Income Statement & Financial Overview
Explore comprehensive income reports for Euroapi S.A. EAPIF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $463.20M | $450.90M | $516.60M | $260.20M |
| Cost of Revenue | $423.70M | $352.90M | $452.10M | $226.45M |
| Gross Profit | $39.50M | $98.00M | $64.50M | $33.75M |
| Gross Profit Ratio | $0.09 | $0.22 | $0.12 | $0.13 |
| R&D Expenses | $11.90M | $13.90M | $16.30M | $8.15M |
| SG&A Expenses | $61.70M | $66.60M | $66.80M | $34.10M |
| Operating Expenses | $68.50M | $131.40M | $79.30M | $159.20M |
| Total Costs & Expenses | -$492.20M | $484.30M | $531.40M | $385.65M |
| Interest Income | $3.00M | $6.20M | $2.20M | $2.25M |
| Interest Expense | $13.50M | $22.40M | $7.90M | $0.00 |
| Depreciation & Amortization | $30.90M | $27.50M | $41.70M | $129.55M |
| EBITDA | -$53.60M | -$4.90M | $26.90M | $121.25M |
| EBITDA Ratio | -$0.12 | -$0.01 | $0.05 | $0.47 |
| Operating Income | -$29.00M | -$33.40M | -$14.80M | -$8.30M |
| Operating Income Ratio | -$0.06 | -$0.07 | -$0.03 | -$0.03 |
| Other Income/Expenses (Net) | -$69.10M | -$8.10M | -$2.55M | -$2.55M |
| Income Before Tax | -$98.10M | -$41.50M | -$255.50M | -$127.70M |
| Income Before Tax Ratio | -$0.21 | -$0.09 | -$0.49 | -$0.49 |
| Income Tax Expense | -$2.30M | -$6.70M | -$3.00M | $1.45M |
| Net Income | -$95.80M | -$34.80M | -$252.50M | -$126.25M |
| Net Income Ratio | -$0.21 | -$0.08 | -$0.49 | -$0.49 |
| EPS | -$1.01 | -$0.37 | -$2.66 | -$1.34 |
| Diluted EPS | -$1.01 | -$0.36 | -$2.66 | -$1.34 |
| Weighted Avg Shares Outstanding | $95.23M | $94.05M | $94.84M | $94.20M |
| Weighted Avg Shares Outstanding (Diluted) | $95.23M | $95.90M | $94.84M | $94.50M |
Over the past four quarters, Euroapi S.A. demonstrated steady revenue growth, increasing from $260.20M in Q3 2023 to $463.20M in Q4 2024. Operating income reached -$29.00M in Q4 2024, maintaining a consistent -6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$53.60M, reflecting operational efficiency. Net income dropped to -$95.80M, with EPS at -$1.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan